Meril

Focus: Meril is a medical device and diagnostics company headquartered in Vapi, India, specializing in cardiovascular interventions including stents, transcatheter heart valves, and surgical devices. Founded in 2006, it operates as a mid-cap medical device manufacturer with a diversified portfolio across interventional cardiology and orthopedics.

Cardiovascular

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Meril

AI assessmentNot Hiring

No open roles listed right now. Follow Meril to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

19 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Myval THV Series

Aortic Valve Stenosis

Growth

Transcatheter heart valve system addressing a high-volume, recurring cardiac intervention market.

BioMime™ Morph - Sirolimus Eluting Coronary Stent System

Coronary Artery Disease

Help build intelligence for Meril

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diversified cardiovascular device portfolio with 18 active clinical programs spanning coronary stents, bioresorbable scaffolds, TAVR systems, and surgical devices
Established player with 18+ years of operational history and multiple marketed products indicating stable commercial infrastructure
India-based headquarters provides cost-of-living advantages and potential exposure to emerging market device manufacturing

Watch Out For

No active job postings currently listed, suggesting minimal near-term hiring momentum or potential hiring freeze
Limited publicly available financial data (revenue, R&D spend, cash position) makes it difficult to assess stability and growth trajectory

Generated by Claude from Meril's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Second-generation drug-eluting stent competing in a mature but large coronary interventions market.

MeRes100 Sirolimus-Eluting BioResorbable Vascular Scaffold System

Coronary Artery Disease

Growth

Next-generation bioresorbable scaffold technology with differentiation potential in coronary disease.

Mozec™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter

Coronary Artery Disease

Growth

Balloon catheter with drug elution for percutaneous coronary intervention procedures.

Freedom® Total Knee System

Knee Osteoarthritis

Stable

Orthopedic prosthetic device diversifying portfolio beyond cardiovascular focus.

Dafodil™ / Dafodil Neo™ Pericardial Bioprosthetic Heart Valve

Aortic Valve Disease, Mitral Valve Disease, Prosthetic Heart Valve Dysfunction

Growth

Surgical bioprosthetic valve for both aortic and mitral positions with revision capability.

Pipeline & Clinical Trials

Mozec™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT06197022Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

N/A

Freedom® Total Knee System

Knee Osteoarthritis

N/A

Clinical Trials (1)

NCT04033588Freedom® Total Knee System for Treatment of Osteoarthritis, Rheumatoid Arthritis or Post-traumatic Arthritis

N/A

MeRes100 Sirolimus-Eluting BioResorbable Vascular Scaffold System

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT03454724Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease.

N/A

Sirolimus Eluting Coronary Stent System

Angina Pectoris

N/A

Clinical Trials (1)

NCT02901353A Prospective, Single-arm, Multi-centre, Observational, Real World Registry

N/A

BioMime™ Morph - Sirolimus Eluting Coronary Stent System

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT03721614Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.

N/A

MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT05417893Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions

N/A

Sirolimus Eluting Coronary Stent

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT02112981BioMime Vs. Xience Randomised Control Clinical Study

N/A

BioMimeTM Stent, Ultimaster® Stent

Ischemic Heart Disease

N/A

Clinical Trials (1)

NCT02986295Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent

N/A

Sirolimus Eluting Coronary Stent System

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT01507519Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions

N/A

MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT02663323Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

N/A

An Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study.

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT02406326An Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study.

N/A

TAVR

Severe Aortic Valve Stenosis

N/A

Clinical Trials (1)

NCT06917066MYLEAD Spanish Prospective Registry

N/A

Myval THV Series

Aortic Valve Stenosis

N/A

Clinical Trials (1)

NCT04275726LANDMARK Trial: a Randomised Controlled Trial of Myval THV

N/A

Myval THV series

Aortic Valve Stenosis

N/A

Clinical Trials (1)

NCT06818435Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry

N/A

Three-row circular stapler

Anastomotic Leak

N/A

Clinical Trials (1)

NCT03910699THREE-row Circular STAPLER in Low Anterior Resection for Rectal Cancer

N/A

Percutaneous coronary intervention with protocolized implantation of a second generation thin-strut bioresorbable scaffold guided by intracoronary imaging

Coronary Arterial Disease (CAD)

N/A

Clinical Trials (1)

NCT06919562OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure

N/A

Myval Transcatheter Heart Valve Series

Aortic Valve Stenosis

N/A

Clinical Trials (1)

NCT04703699Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.

N/A

Dafodil™ / Dafodil Neo™ Pericardial Bioprosthetic Heart Valve

Aortic Valve Disease, Mitral Valve Disease, Prosthetic Heart Valve Dysfunction

N/A

Clinical Trials (1)

NCT07379112Safety and Performance of Dafodil Heart Valves in Real-World Aortic and Mitral Valve Replacement

N/A

Transcatheter aortic valve replacement

Moderate Aortic Valve Stenosis

N/A

Clinical Trials (1)

NCT07532317To Evaluate Safety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series Compared toGuideline-Directed Medical Therapy (GDMT) in Participants With Moderate Aortic Stenosis.

N/A